Skip to main content

Table 2 Risk classification of local recurrence at various anatomic sites and recommended delineation of clinical target volume

From: Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation

T1-2(N = 33)

T3-4(N = 19)

Anatomic sites

No

Percentage

Risk of recurrence

Anatomic sites

No

Percentage

Risk of recurrence

Levator veli palatine muscle

26

78.8%

High

Levator veli palatine muscle

14

73.7%

High

Nasopharynx

25

75.8%

 

Nasopharynx

14

73.7%

 

Prevertebral muscle

24

72.7%

 

Prevertebral muscle

11

57.9%

 

Tensor veli palatine muscle

20

60.6%

 

Tensor veli palatine muscle

11

57.9%

 

Retropharyngeal lymph node

20

60.6%

 

Foramen lacerum

11

57.9%

 

Foramen lacerum

17

51.5%

 

Posterior Nasal cavity

10

52.6%

 

Bottom of sphenoid sinus

17

51.5%

 

Great wing of sphenoid bone

9

47.4%

 

Pterygoid process

14

42.4%

 

Bottom of sphenoid sinus

9

47.4%

 

Great wing of sphenoid bone

11

33.3%

 

Pterygoid process

8

42.1%

 

Parapharyngeal space

11

33.3%

 

Petrous apex

8

42.1%

 

Sphenoid sinus

10

30.3%

 

Clivus

8

42.1%

 

Petrous apex

8

24.2%

Median

Retropharyngeal lymph node

7

36.8%

 

Posterior Nasal cavity

7

21.2%

 

Pterygopalatine fossa

7

36.8%

 

Jugular Foramen

7

21.2%

 

Parapharyngeal Space

6

31.6%

 

Clivus

6

18.2%

 

Sphenoid sinus

6

31.6%

 

Pterygopalatine fossa

6

18.2%

 

Jugular Foramen

5

26.3%

Median

Medial pterygoid muscle

6

18.2%

 

Posterior ethmoid sinusa

4

21.1%

 

Foramen ovale

6

18.2%

 

Hypoglossal canala

4

21.1%

 

Foramen rotundum

4

12.1%

Low

Lateral pterygoid musclea

4

21.1%

 

Posterior ethmoid sinus

3

9.1%

 

Foramen rotunduma

3

15.8%

 

Inferior orbital fissure

3

9.1%

 

Inferior orbital fissurea

3

15.8%

 

Anterior ethmoid sinus

3

9.1%

 

Cavernous sinusa

3

15.8%

 

Oropharynx

2

6.1%

 

Medial pterygoid muscleb

2

10.5%

Low

Anterior Nasal cavity

2

6.1%

 

Orbit

2

10.5%

 

Frontal sinus

2

6.1%

 

Foramen ovaleb

1

5.3%

 

Hypoglossal canal

1

3.0%

 

Anterior ethmoid sinus

1

5.3%

 

Lateral pterygoid muscle

1

3.0%

 

Oropharynx

1

5.3%

 

Cavernous sinus

1

3.0%

 

Anterior Nasal cavity

1

5.3%

 

Orbit

1

3.0%

 

Maxillary sinus

1

5.3%

 

Maxillary sinus

1

3.0%

 

Cervical vertebrae

1

5.3%

 

Cervical vertebrae

0

0.0%

 

Frontal sinus

0

0.0%

 

Infratemporal fossa

0

0.0%

 

Infratemporal fossa

0

0.0%

 

Hypopharynx

0

0.0%

 

Hypopharynx

0

0.0%

 
  1. The anatomic sties with median or high risk should be included in the contouring of CTV
  2. aThe possibility of invasion of these structures was higher in cases with T3-4 (≥ 15%) than cases with T1-2 (< 15%). These anatomic structures were recommended to be included in CTV in locally advanced cases (T3-4)
  3. bAlthough the possibility of invasion of these structures was low in T3-4 cases (< 15%), they were recommended to be included due to median risk of involvement in early-stage diseases (T1-2)